🇺🇸 Eszopiclone (Lunesta) in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Chest Discomfort — 1 report (10%)
  2. Dysphagia — 1 report (10%)
  3. Dyspnoea — 1 report (10%)
  4. Erythema — 1 report (10%)
  5. Erythema Multiforme — 1 report (10%)
  6. Flushing — 1 report (10%)
  7. Herpes Zoster — 1 report (10%)
  8. Hyperhidrosis — 1 report (10%)
  9. Hypersensitivity — 1 report (10%)
  10. Meningitis Viral — 1 report (10%)

Source database →

Other Neurology / Sleep Medicine approved in United States

Frequently asked questions

Is Eszopiclone (Lunesta) approved in United States?

Eszopiclone (Lunesta) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Eszopiclone (Lunesta) in United States?

Sumitomo Pharma America, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.